European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids.

Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1238 (Electronic) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE

Publication: New York : Springer Verlag
Original Publication: Berlin ; New York, Springer International.

Fluid Therapy*/methods ; Fluid Therapy*/standards ; Critical Illness*/therapy ; Critical Care*/methods ; Critical Care*/standards ; Crystalloid Solutions*/administration & dosage ; Crystalloid Solutions*/therapeutic use ; Resuscitation*/methods ; Resuscitation*/standards; Humans ; Adult ; Europe ; Albumins/therapeutic use ; Albumins/administration & dosage ; Sepsis/therapy

Purpose: This is the first of three parts of the clinical practice guideline from the European Society of Intensive Care Medicine (ESICM) on resuscitation fluids in adult critically ill patients. This part addresses fluid choice and the other two will separately address fluid amount and fluid removal.
Methods: This guideline was formulated by an international panel of clinical experts and methodologists. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was applied to evaluate the certainty of evidence and to move from evidence to decision.
Results: For volume expansion, the guideline provides conditional recommendations for using crystalloids rather than albumin in critically ill patients in general (moderate certainty of evidence), in patients with sepsis (moderate certainty of evidence), in patients with acute respiratory failure (very low certainty of evidence) and in patients in the perioperative period and patients at risk for bleeding (very low certainty of evidence). There is a conditional recommendation for using isotonic saline rather than albumin in patients with traumatic brain injury (very low certainty of evidence). There is a conditional recommendation for using albumin rather than crystalloids in patients with cirrhosis (very low certainty of evidence). The guideline provides conditional recommendations for using balanced crystalloids rather than isotonic saline in critically ill patients in general (low certainty of evidence), in patients with sepsis (low certainty of evidence) and in patients with kidney injury (very low certainty of evidence). There is a conditional recommendation for using isotonic saline rather than balanced crystalloids in patients with traumatic brain injury (very low certainty of evidence). There is a conditional recommendation for using isotonic crystalloids rather than small-volume hypertonic crystalloids in critically ill patients in general (very low certainty of evidence).
Conclusions: This guideline provides eleven recommendations to inform clinicians on resuscitation fluid choice in critically ill patients.
(© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.)

Vincent JL, De Backer D (2013) Circulatory shock. N Engl J Med 369:1726–1734. (PMID: 2417151810.1056/NEJMra1208943)
Hammond NE, Taylor C, Finfer S, Machado FR, An Y, Billot L, Bloos F, Bozza F, Cavalcanti AB, Correa M, Du B, Hjortrup PB, Li Y, McIntryre L, Saxena M, Schortgen F, Watts NR, Myburgh J, Fluid-TRIPS and Fluidos Investigators; George Institute for Global Health, The ANZICS Clinical Trials Group, BRICNet, and the REVA research Network (2017) Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: an international cross-sectional study. PLoS One 12:e0176292.
Myburgh JA, Mythen MG (2013) Resuscitation fluids. N Engl J Med 369:2462–2463. (PMID: 2435096610.1056/NEJMra1208627)
Cecconi M, Kesecioglu J, Azoulay E, European Society of Intensive Care Medicine (2021) Diversity and inclusivity: the way to multidisciplinary intensive care medicine in Europe. Intensive Care Med 47:598–601. (PMID: 33914111808247610.1007/s00134-021-06384-4)
Alhazzani W, Lewis K, Jaeschke R, Rochwerg B, Moller MH, Evans L, Wilson KC, Patel S, Coopersmith CM, Cecconi M, Guyatt G, Akl EA (2018) Conflicts of interest disclosure forms and management in critical care clinical practice guidelines. Intensive Care Med 44:1691–1698. (PMID: 3026438010.1007/s00134-018-5367-6)
SAFE Study Investigators, Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R (2011) Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37:86–96. (PMID: 10.1007/s00134-010-2039-6)
Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, ALBIOS Study Investigators (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412–1421. (PMID: 2463577210.1056/NEJMoa1305727)
Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64:395–400. (PMID: 2119489110.1016/j.jclinepi.2010.09.012)
Lewis SR, Pritchard MW, Evans DJ, Butler AR, Alderson P, Smith AF, Roberts I (2018) Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 8:CD000567. (PMID: 30073665)
Tseng CH, Chen TT, Wu MY, Chan MC, Shih MC, Tu YK (2020) Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses. Crit Care 24:693. (PMID: 33317590773486310.1186/s13054-020-03419-y)
Bai Z, Wang L, Wang R, Zou M, Mendez-Sanchez N, Romeiro FG, Cheng G, Qi X (2022) Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials. Hepatol Int 16:1468–1483. (PMID: 3604831810.1007/s12072-022-10374-z)
Wan S, Roberts MA, Mount P (2016) Normal saline versus lower-chloride solutions for kidney transplantation. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD010741.pub2. (PMID: 10.1002/14651858.CD010741.pub2276417186457833)
Hammond NE, Zampieri FG, Tanna GLD, Garside T, Adigbli D, Cavalcanti AB, Machado FR, Micallef S, Myburgh J, Ramanan M, Rice TW, Semler MW, Young PJ, Venkatesh B, Finfer S, Delaney A, (2022) Balanced Crystalloids versus Saline in Critically Ill Adults — A Systematic Review with Meta-Analysis. NEJM Evidence 1: EVIDoa2100010.
Zampieri FG, Cavalcanti AB, Di Tanna GL, Damiani LP, Hammond NE, Machado FR, Micallef S, Myburgh J, Ramanan M, Venkatesh B, Rice TW, Semler MW, Young PJ, Finfer S (2024) Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis. Lancet Respir Med 12(3):237–246.
Orbegozo D, Vincent JL, Creteur J, Su F (2019) Hypertonic saline in human sepsis: a systematic review of randomized controlled trials. Anesth Analg 128:1175–1184. (PMID: 3109478510.1213/ANE.0000000000003955)
DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. (PMID: 26343745463942010.1016/j.cct.2015.09.002)
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. (PMID: 380283310.1016/0197-2456(86)90046-2)
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. (PMID: 1295812019285910.1136/bmj.327.7414.557)
Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, Brignardello-Petersen R, Carrasco-Labra A, De Beer H, Hultcrantz M, Kuijpers T, Meerpohl J, Morgan R, Mustafa R, Skoetz N, Sultan S, Wiysonge C, Guyatt G, Schunemann HJ, Group GW (2020) GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol 119:126–135. (PMID: 3171191210.1016/j.jclinepi.2019.10.014)
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926. (PMID: 18436948233526110.1136/bmj.39489.470347.AD)
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406. (PMID: 2120877910.1016/j.jclinepi.2010.07.015)
Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coello P, Atkins D, Kunz R, Montori V, Jaeschke R, Rind D, Dahm P, Akl EA, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Schunemann HJ (2013) GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol 66:151–157. (PMID: 2254202310.1016/j.jclinepi.2012.01.006)
Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, Nasser M, Meerpohl J, Post PN, Kunz R, Brozek J, Vist G, Rind D, Akl EA, Schunemann HJ (2013) GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66:719–725. (PMID: 2331239210.1016/j.jclinepi.2012.03.013)
GRADE Handbook. https://gdt.gradepro.org/app/handbook/handbook.html#:~:text=In%20general%2C%20it%20seems%20preferable%20to%20present%20recommendations%20in%20favor%20of%20a%20particular%20management%20approach%20rather%20than%20against%20an%20alternative . Accessed March 24–2024.
Michel CC, Woodcock TE, Curry FE (2020) Understanding and extending the Starling principle. Acta Anaesthesiol Scand 64:1032–1037. (PMID: 3227049110.1111/aas.13603)
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256. (PMID: 1516377410.1056/NEJMoa040232)
Runken MC, Caraceni P, Fernandez J, Zipprich A, Carlton R, Bunke M (2019) The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain. Health Econ Rev 9:22. (PMID: 31278624673426510.1186/s13561-019-0237-7)
Taylor C, Yang L, Finfer S, Machado FR, YouZhong A, Billot L, Bloos F, Bozza F, Cavalcanti AB, Correa M, Du B, Hjortrup PB, McIntyre L, Saxena M, Schortgen F, Watts NR, Myburgh J, Thompson K, Hammond NE, Fluid-TRIPS and Fluidos Investigators, The George Institute for Global Health, The ANZICS Clinical Trials Group, BRICNet, and the REVA Research Network (2021) An international comparison of the cost of fluid resuscitation therapies. Aust Crit Care 34:23–32. (PMID: 3282867210.1016/j.aucc.2020.06.001)
Farrugia A, Bansal M, Balboni S, Kimber MC, Martin GS, Cassar J (2014) Choice of fluids in severe septic patients—a cost-effectiveness analysis informed by recent clinical trials. Rev Recent Clin Trials 9:21–30. (PMID: 24330133411237810.2174/1574887108666131213120816)
Guidet B, Mosqueda GJ, Priol G, Aegerter P (2007) The COASST study: cost-effectiveness of albumin in severe sepsis and septic shock. J Crit Care 22:197–203. (PMID: 1786996910.1016/j.jcrc.2006.11.005)
Tigabu B, Davari M, Kebriaeezadeh A, Mojtahedzadeh M, Sadeghi K, Jahangard-Rafsanjani Z (2019) Is albumin-based resuscitation in severe sepsis and septic shock justifiable? An evidence from a cost-effectiveness evaluation. Ethiop J Health Sci 29:869–876. (PMID: 307009546341442)
Tigabu BM, Davari M, Kebriaeezadeh A, Mojtahedzadeh M, Sadeghi K, Najmeddin F, Jahangard-Rafsanjani Z (2019) A cost-effectiveness analysis of albumin in septic shock: a patient-level data analysis. Clin Ther 41(2297–2307):e2292.
Vincent JL, Wilkes MM, Navickis RJ (2003) Safety of human albumin–serious adverse events reported worldwide in 1998–2000. Br J Anaesth 91:625–630. (PMID: 1457078210.1093/bja/aeg233)
von Hoegen I, Waller C (2001) Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med 29:994–996. (PMID: 10.1097/00003246-200105000-00021)
Zampieri FG, Bagshaw SM, Semler MW (2023) Fluid therapy for critically Ill adults with sepsis: a review. JAMA 329:1967–1980. (PMID: 3731427110.1001/jama.2023.7560)
Hahn RG (2020) Understanding volume kinetics. Acta Anaesthesiol Scand 64:570–578. (PMID: 3186345710.1111/aas.13533)
Kremer H, Baron-Menguy C, Tesse A, Gallois Y, Mercat A, Henrion D, Andriantsitohaina R, Asfar P, Meziani F (2011) Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: concentration-dependent properties. Crit Care Med 39:1414–1422. (PMID: 2133611910.1097/CCM.0b013e318211ff6e)
Hogue B, Chagnon F, Lesur O (2012) Resuscitation fluids and endotoxin-induced myocardial dysfunction: is selection a load-independent differential issue? Shock 38:307–313. (PMID: 2277711010.1097/SHK.0b013e31825e7ae9)
Vincent JL, De Backer D, Wiedermann CJ (2016) Fluid management in sepsis: the potential beneficial effects of albumin. J Crit Care 35:161–167. (PMID: 2748175310.1016/j.jcrc.2016.04.019)
Semler MW, Rice TW (2016) Sepsis resuscitation: fluid choice and dose. Clin Chest Med 37:241–250. (PMID: 27229641488430410.1016/j.ccm.2016.01.007)
Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declere AD, Preiser JC, Outin H, Troche G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Reignier J, Abroug F, Berger P, Clec’h C, Cousson J, Thibault L, Chevret S, Investigators C (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310:1809–1817. (PMID: 2410851510.1001/jama.2013.280502)
SAFE Study Investigators, Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, Norton R (2006) Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 333:1044. (PMID: 10.1136/bmj.38985.398704.7C)
Malbrain M, Van Regenmortel N, Saugel B, De Tavernier B, Van Gaal PJ, Joannes-Boyau O, Teboul JL, Rice TW, Mythen M, Monnet X (2018) Principles of fluid management and stewardship in septic shock: it is time to consider the four D’s and the four phases of fluid therapy. Ann Intensive Care 8:66. (PMID: 29789983596405410.1186/s13613-018-0402-x)
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A, LUNG SAFE Investigators; ESICM Trials Group (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788–800. (PMID: 2690333710.1001/jama.2016.0291)
Pisani L, Algera AG, Neto AS, Azevedo L, Pham T, Paulus F, de Abreu MG, Pelosi P, Dondorp AM, Bellani G, Laffey JG, Schultz MJ, ERICC study investigators; LUNG SAFE study investigators; PRoVENT study investigators; PRoVENT-iMiC study investigators (2022) Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies. Lancet Glob Health 10:e227–e235. (PMID: 3491489910.1016/S2214-109X(21)00485-X)
Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG, Calfee CS (2019) Acute respiratory distress syndrome. Nat Rev Dis Primers 5:18. (PMID: 30872586670967710.1038/s41572-019-0069-0)
Mendes RS, Pelosi P, Schultz MJ, Rocco PRM, Silva PL (2020) Fluids in ARDS: more pros than cons. Intensive Care Med Exp 8:32. (PMID: 33336259774642810.1186/s40635-020-00319-x)
Uhlig C, Silva PL, Deckert S, Schmitt J, de Abreu MG (2014) Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care 18:R10. (PMID: 24405693405610610.1186/cc13187)
Metildi LA, Shackford SR, Virgilio RW, Peters RM (1984) Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet 158:207–212. (PMID: 6701732)
van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB (2009) Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 37:1275–1281. (PMID: 1924233810.1097/CCM.0b013e31819cedfd)
Carney N, Totten AM, O’Reilly C, Ullman JS, Hawryluk GW, Bell MJ, Bratton SL, Chesnut R, Harris OA, Kissoon N, Rubiano AM, Shutter L, Tasker RC, Vavilala MS, Wilberger J, Wright DW, Ghajar J (2017) Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery 80:6–15. (PMID: 2765400010.1227/NEU.0000000000001432)
SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health; Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, Kai Lo S, Vallance S (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357:874–884. (PMID: 10.1056/NEJMoa067514)
Cooper DJ, Myburgh J, Heritier S, Finfer S, Bellomo R, Billot L, Murray L, Vallance S, SAFE-TBI Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group (2013) Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma 30:512–518. (PMID: 23194432363658110.1089/neu.2012.2573)
Iguchi N, Kosaka J, Bertolini J, May CN, Lankadeva YR, Bellomo R (2018) Differential effects of isotonic and hypotonic 4% albumin solution on intracranial pressure and renal perfusion and function. Crit Care Resusc 20:48–53. (PMID: 29458321)
Wiedermann CJ (2022) Use of hyperoncotic human albumin solution in severe traumatic brain injury revisited—a narrative review and meta-analysis. J Clin Med 11:2662. (PMID: 35566786909994610.3390/jcm11092662)
Kozek-Langenecker SA (2015) Fluids and coagulation. Curr Opin Crit Care 21:285–291. (PMID: 2610314310.1097/MCC.0000000000000219)
Rasmussen KC, Secher NH, Pedersen T (2016) Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: a systematic review and stratified meta-analysis. Medicine (Baltimore) 95:e4498. (PMID: 2749509810.1097/MD.0000000000004498)
Hussmann B, Lefering R, Waydhas C, Touma A, Kauther MD, Ruchholtz S, Lendemans S, Trauma Registry of the German Society for Trauma Surgery (2013) Does increased prehospital replacement volume lead to a poor clinical course and an increased mortality? A matched-pair analysis of 1896 patients of the Trauma Registry of the German Society for Trauma Surgery who were managed by an emergency doctor at the accident site. Injury 44:611–617. (PMID: 2237727610.1016/j.injury.2012.02.004)
Durand F, Kellum JA, Nadim MK (2023) Fluid resuscitation in patients with cirrhosis and sepsis: a multidisciplinary perspective. J Hepatol 79:240–246. (PMID: 3686848010.1016/j.jhep.2023.02.024)
Valerio C, Theocharidou E, Davenport A, Agarwal B (2016) Human albumin solution for patients with cirrhosis and acute on chronic liver failure: beyond simple volume expansion. World J Hepatol 8:345–354. (PMID: 26981172477916310.4254/wjh.v8.i7.345)
Best LM, Freeman SC, Sutton AJ, Cooper NJ, Tng EL, Csenar M, Hawkins N, Pavlov CS, Davidson BR, Thorburn D, Cowlin M, Milne EJ, Tsochatzis E, Gurusamy KS (2019) Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 9:CD013103. (PMID: 31513287)
Benmassaoud A, Freeman SC, Roccarina D, Plaz Torres MC, Sutton AJ, Cooper NJ, Iogna Prat L, Cowlin M, Milne EJ, Hawkins N, Davidson BR, Pavlov CS, Thorburn D, Tsochatzis E, Gurusamy KS (2020) Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 1:CD013123. (PMID: 31978257)
Simonetti RG, Perricone G, Nikolova D, Bjelakovic G, Gluud C (2019) Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Cochrane Database Syst Rev 6:CD004039. (PMID: 31251387)
Leao GS, John Neto G, Jotz RF, Mattos AA, Mattos AZ (2019) Albumin for cirrhotic patients with extraperitoneal infections: a meta-analysis. J Gastroenterol Hepatol 34:2071–2076. (PMID: 3135363010.1111/jgh.14791)
Bombassaro IZ, Tovo CV, de Mattos AZ, Ahlert M, Chiesa T, de Mattos AA (2021) Albumin in the management of hepatic encephalopathy: a systematic review and meta-analysis. Ann Hepatol 26:100541. (PMID: 3460014310.1016/j.aohep.2021.100541)
Teh KB, Loo JH, Tam YC, Wong YJ (2021) Efficacy and safety of albumin infusion for overt hepatic encephalopathy: a systematic review and meta-analysis. Dig Liver Dis 53:817–823. (PMID: 3401147910.1016/j.dld.2021.04.030)
Ashour AA, Atta MA, Sadek KW, Obaid KR, Ashour MA, Ashour A, Danjuma MI, Doi SA, ElZouki AN (2021) Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update. Eur J Gastroenterol Hepatol 33:479–486. (PMID: 3297619010.1097/MEG.0000000000001932)
Xu T, Liu W, Huang R (2023) Can albumin reduce the mortality of patients with cirrhosis and ascites? A meta-analysis of randomized controlled trials. Eur J Gastroenterol Hepatol 35:80–88. (PMID: 3616506710.1097/MEG.0000000000002447)
Zaccherini G, Tufoni M, Bernardi M (2020) Albumin administration is efficacious in the management of patients with cirrhosis: a systematic review of the literature. Hepat Med 12:153–172. (PMID: 33149707760289010.2147/HMER.S264231)
Simon-Talero M, Garcia-Martinez R, Torrens M, Augustin S, Gomez S, Pereira G, Guevara M, Gines P, Soriano G, Roman E, Sanchez-Delgado J, Ferrer R, Nieto JC, Sunye P, Fuentes I, Esteban R, Cordoba J (2013) Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol 59:1184–1192. (PMID: 2387260510.1016/j.jhep.2013.07.020)
Philips CA, Maiwall R, Sharma MK, Jindal A, Choudhury AK, Kumar G, Bhardwaj A, Mitra LG, Agarwal PM, Sarin SK (2021) Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial. Hepatol Int 15:983–994. (PMID: 3403651910.1007/s12072-021-10164-z)
Maiwall R, Kumar A, Pasupuleti SSR, Hidam AK, Tevethia H, Kumar G, Sahney A, Mitra LG, Sarin SK (2022) A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. J Hepatol 77:670–682. (PMID: 3546072510.1016/j.jhep.2022.03.043)
Freitas FGR, Hammond N, Li Y, Azevedo LCP, Cavalcanti AB, Taniguchi L, Gobatto A, Japiassu AM, Bafi AT, Mazza BF, Noritomi DT, Dal-Pizzol F, Bozza F, Salluh JIF, Westphal GA, Soares M, Assuncao MSC, Lisboa T, Lobo SMA, Barbosa AR, Ventura AF, Souza AF, Silva AF, Toledo A, Reis A, Cembranel A, Rea Neto A, Gut AL, Justo APP, Santos AP, Albuquerque ACD, Scazufka A, Rodrigues AB, Fernandino BB, Silva BG, Vidal BS, Pinheiro BV, Pinto BVC, Feijo CAR, Abreu Filho C, Bosso C, Moreira CEN, Ramos CHF, Tavares C, Arantes C, Grion C, Mendes CL, Kmohan C, Piras C, Castro CPP, Lins C, Beraldo D, Fontes D, Boni D, Castiglioni D, Paisani DM, Pedroso DFF, Mattos ER, Brito Sobrinho E, Troncoso EMV, Rodrigues Filho EM, Nogueira EEF, Ferreira EL, Pacheco ES, Jodar E, Ferreira ELA, Araujo FF, Trevisol FS, Amorim FF, Giannini FP, Santos FPM, Buarque F, Lima FG, Costa F, Sad F, Aranha FG, Ganem F, Callil F, Costa Filho FF, Dall Arto FTC, Moreno G, Friedman G, Moralez GM, Silva GAD, Costa G, Cavalcanti GS, Cavalcanti GS, Betonico GN, Betonico GN, Reis H, Araujo HBN, Hortiz Junior HA, Guimaraes HP, Urbano H, Maia I, Santiago Filho IL, Farhat Junior J, Alvarez JR, Passos JT, Paranhos J, Marques JA, Moreira Filho JG, Andrade JN, Sobrinho JOC, Bezerra JTP, Alves JA, Ferreira J, Gomes J, Sato KM, Gerent K, Teixeira KMC, Conde KAP, Martins LF, Figueiredo L, Rezegue L, Tcherniacovsk L, Ferraz LO, Cavalcante L, Rabelo L, Miilher L, Garcia L, Tannous L, Hajjar LA, Paciencia LEM, Cruz Neto LMD, Bley MV, Sousa MF, Puga ML, Romano MLP, Nobrega M, Arbex M, Rodrigues ML, Guerreiro MO, Rocha M, Alves MAP, Alves MAP, Rosa MD, Dias MD, Martins M, Oliveira M, Moretti MMS, Matsui M, Messender O, Santarem OLA, Silveira P, Vassallo PF, Antoniazzi P, Gottardo PC, Correia P, Ferreira P, Torres P, Silva P, Foernges R, Gomes R, Moraes R, Nonato Filho R, Borba RL, Gomes RV, Cordioli R, Lima R, Lopez RP, Gargioni RRO, Rosenblat R, Souza RM, Almeida R, Narciso RC, Marco R, Waltrick R, Biondi R, Figueiredo R, Dutra RS, Batista R, Felipe R, Franco R, Houly S, Faria SS, Pinto SF, Luzzi S, Sant’ana S, Fernandes SS, Yamada S, Zajac S, Vaz SM, Bezerra SAB, Farhat TBT, Santos TM, Smith T, Silva UVA, Damasceno VB, Nobre V, Dantas VCS, Irineu VM, Bogado V, Nedel W, Campos Filho W, Dantas W, Viana W, Oliveira Filho W, Delgadinho WM, Finfer S, Machado FR (2021) Resuscitation fluid practices in Brazilian intensive care units: a secondary analysis of Fluid-TRIPS. Rev Bras Ter Intensiva 33:206–218. (PMID: 34231801827508910.5935/0103-507X.20210028)
Finfer S, Myburgh J, Bellomo R (2018) Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol 14:541–557. (PMID: 3007271010.1038/s41581-018-0044-0)
Soussi S, Ferry A, Chaussard M, Legrand M (2017) Chloride toxicity in critically ill patients: what’s the evidence? Anaesth Crit Care Pain Med 36:125–130. (PMID: 2747682710.1016/j.accpm.2016.03.008)
Hammond DA, Lam SW, Rech MA, Smith MN, Westrick J, Trivedi AP, Balk RA (2020) Balanced crystalloids versus saline in critically ill adults: a systematic review and meta-analysis. Ann Pharmacother 54:5–13. (PMID: 3136438210.1177/1060028019866420)
Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, Du B, McArthur C, Myburgh J, Investigators ST (2010) Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 14:R185. (PMID: 20950434321929110.1186/cc9293)
Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M (2012) Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308:1566–1572. (PMID: 2307395310.1001/jama.2012.13356)
Brown RM, Wang L, Coston TD, Krishnan NI, Casey JD, Wanderer JP, Ehrenfeld JM, Byrne DW, Stollings JL, Siew ED, Bernard GR, Self WH, Rice TW, Semler MW (2019) Balanced crystalloids versus saline in sepsis. a secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med 200:1487–1495. (PMID: 31454263690984510.1164/rccm.201903-0557OC)
Raghunathan K, Shaw A, Nathanson B, Sturmer T, Brookhart A, Stefan MS, Setoguchi S, Beadles C, Lindenauer PK (2014) Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 42:1585–1591. (PMID: 2467492710.1097/CCM.0000000000000305)
Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R, Investigators S, ANZICS CTG (2015) Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA 314:1701–1710. (PMID: 2644469210.1001/jama.2015.12334)
Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, Wang L, Byrne DW, Shaw AD, Bernard GR, Rice TW, SI, the Pragmatic Critical Care Research G, Investigators S (2017) Balanced crystalloids versus saline in the intensive care unit the SALT randomized trial. Am J Respir Crit Care Med 195:1362–1372. (PMID: 27749094544390010.1164/rccm.201607-1345OC)
Semler MW, Self WH, Rice TW (2018) Balanced crystalloids versus saline in critically ill adults. N Engl J Med 378:1951. (PMID: 29768150657041010.1056/NEJMoa1711584)
Finfer S, Micallef S, Hammond N, Navarra L, Bellomo R, Billot L, Delaney A, Gallagher M, Gattas D, Li Q, Mackle D, Mysore J, Saxena M, Taylor C, Young P, Myburgh J, PLUS Study Investigators and the Australian New Zealand Intensive Care Society Clinical Trials Group (2022) Balanced multielectrolyte solution versus saline in critically ill adults. N Engl J Med 386:815–826. (PMID: 3504178010.1056/NEJMoa2114464)
Zampieri FG, Machado FR, Biondi RS, Freitas FGR, Veiga VC, Figueiredo RC, Lovato WJ, Amendola CP, Serpa-Neto A, Paranhos JLR, Guedes MAV, Lucio EA, Oliveira-Junior LC, Lisboa TC, Lacerda FH, Maia IS, Grion CMC, Assuncao MSC, Manoel ALO, Silva-Junior JM, Duarte P, Soares RM, Miranda TA, de Lima LM, Gurgel RM, Paisani DM, Correa TD, Azevedo LCP, Kellum JA, Damiani LP, Brandao da Silva N, Cavalcanti AB, BaSICS investigators and the BRICNet members (2021) Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial. JAMA 326:1–12. (PMID: 343753948356145)
Ramming S, Shackford SR, Zhuang J, Schmoker JD (1994) The relationship of fluid balance and sodium administration to cerebral edema formation and intracranial pressure in a porcine model of brain injury. J Trauma 37:705–713. (PMID: 796646610.1097/00005373-199411000-00003)
Williams EL, Hildebrand KL, McCormick SA, Bedel MJ (1999) The effect of intravenous lactated Ringer’s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 88:999–1003. (PMID: 10320158)
Rowell SE, Fair KA, Barbosa RR, Watters JM, Bulger EM, Holcomb JB, Cohen MJ, Rahbar MH, Fox EE, Schreiber MA (2016) The impact of pre-hospital administration of lactated ringer’s solution versus normal saline in patients with traumatic brain injury. J Neurotrauma 33:1054–1059. (PMID: 26914721489221410.1089/neu.2014.3478)
Lombardo S, Smith MC, Semler MW, Wang L, Dear ML, Lindsell CJ, Freundlich RE, Guillamondegui OD, Self WH, Rice TW, Isotonic S, Major Adverse Renal Events Trial I, Vanderbilt Learning Healthcare System Platform I (2022) Balanced crystalloid versus saline in adults with traumatic brain injury: secondary analysis of a clinical trial. J Neurotrauma 39:1159–1167. (PMID: 35443809942278710.1089/neu.2021.0465)
Papasotiriou M, Mpratsiakou A, Georgopoulou G, Ntrinias T, Balta L, Pavlakou P, Goumenos DS, Papachristou E (2023) Normal saline versus balanced crystalloids in patients with prerenal acute kidney injury and pre-existing chronic kidney disease. Rom J Intern Med 61:98–105. (PMID: 36801001)
Jahangir A, Sahra S, Niazi MRK, Siddiqui FS, Anwar MY, Jahangir A, El-Charabaty EJ (2021) Comparison of normal saline solution with low-chloride solutions in renal transplants: a meta-analysis. Kidney Res Clin Pract 40:484–495. (PMID: 34233443847629810.23876/j.krcp.21.027)
Wagener G, Bezinover D, Wang C, Kroepfl E, Diaz G, Giordano C, West J, Kindscher JD, Moguilevitch M, Nicolau-Raducu R, Planinsic RM, Rosenfeld DM, Lindberg S, Schumann R, Pivalizza EG (2021) Fluid management during kidney transplantation: a consensus statement of the committee on transplant anesthesia of the American Society of Anesthesiologists. Transplantation 105:1677–1684. (PMID: 3332376510.1097/TP.0000000000003581)
Collins MG, Fahim MA, Pascoe EM, Hawley CM, Johnson DW, Varghese J, Hickey LE, Clayton PA, Dansie KB, McConnochie RC, Vergara LA, Kiriwandeniya C, Reidlinger D, Mount PF, Weinberg L, McArthur CJ, Coates PT, Endre ZH, Goodman D, Howard K, Howell M, Jamboti JS, Kanellis J, Laurence JM, Lim WH, McTaggart SJ, O’Connell PJ, Pilmore HL, Wong G, Chadban SJ, BEST-Fluids Investigators; Australasian Kidney Trials Network (2023) Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial. Lancet 402:105–117. (PMID: 3734357610.1016/S0140-6736(23)00642-6)
Drobin D, Hahn RG (2002) Kinetics of isotonic and hypertonic plasma volume expanders. Anesthesiology 96:1371–1380. (PMID: 1217004910.1097/00000542-200206000-00016)
Wiegers EJA, Lingsma HF, Huijben JA, Cooper DJ, Citerio G, Frisvold S, Helbok R, Maas AIR, Menon DK, Moore EM, Stocchetti N, Dippel DW, Steyerberg EW, van der Jagt M, CENTER-TBI; OzENTER-TBI Collaboration Groups (2021) Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study. Lancet Neurol 20:627–638. (PMID: 3430278710.1016/S1474-4422(21)00162-9)
Oliveira RP, Velasco I, Soriano FG, Friedman G (2002) Clinical review: hypertonic saline resuscitation in sepsis. Crit Care 6:418–423. (PMID: 1239878113732010.1186/cc1541)
Pascual JL, Khwaja KA, Ferri LE, Giannias B, Evans DC, Razek T, Michel RP, Christou NV (2003) Hypertonic saline resuscitation attenuates neutrophil lung sequestration and transmigration by diminishing leukocyte-endothelial interactions in a two-hit model of hemorrhagic shock and infection. J Trauma 54:121–130. (PMID: 1254490710.1097/00005373-200301000-00015)
Dubick MA, Atkins JL (2003) Small-volume fluid resuscitation for the far-forward combat environment: current concepts. J Trauma 54:S43-45. (PMID: 12768102)
Smith JE, Hall MJ (2004) Hypertonic saline. J R Army Med Corps 150:239–243. (PMID: 1573241010.1136/jramc-150-04-03)
Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, Tremayne AB, Bernard SS, Ponsford J, Investigators HTSS (2004) Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 291:1350–1357. (PMID: 1502640210.1001/jama.291.11.1350)
Orbegozo Cortes D, Rayo Bonor A, Vincent JL (2014) Isotonic crystalloid solutions: a structured review of the literature. Br J Anaesth 112:968–981. (PMID: 2473639310.1093/bja/aeu047)
Roquilly A, Moyer JD, Huet O, Lasocki S, Cohen B, Dahyot-Fizelier C, Chalard K, Seguin P, Jeantrelle C, Vermeersch V, Gaillard T, Cinotti R, Demeure Dit Latte D, Mahe PJ, Vourc’h M, Martin FP, Chopin A, Lerebourg C, Flet L, Chiffoleau A, Feuillet F, Asehnoune K (2021) Effect of continuous infusion of hypertonic saline vs standard care on 6-month neurological outcomes in patients with traumatic brain injury: the COBI randomized clinical trial. JAMA 325:2056–2066. (PMID: 3403282910.1001/jama.2021.5561)
Li B, Zhao H, Zhang J, Yan Q, Li T, Liu L (2020) Resuscitation fluids in septic shock: a network meta-analysis of randomized controlled trials. Shock 53:679–685. (PMID: 3169363010.1097/SHK.0000000000001468)
Bunn F, Roberts I, Tasker R, Akpa E (2004) Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2004:CD002045. (PMID: 152664607017932)
Safiejko K, Smereka J, Pruc M, Ladny JR, Jaguszewski MJ, Filipiak KJ, Yakubtsevich R, Szarpak L (2022) Efficacy and safety of hypertonic saline solutions fluid resuscitation on hypovolemic shock: a systematic review and meta-analysis of randomized controlled trials. Cardiol J 29:966–977. (PMID: 33140397978873410.5603/CJ.a2020.0134)
Pfortmueller CA, Schefold JC (2017) Hypertonic saline in critical illness—a systematic review. J Crit Care 42:168–177. (PMID: 2874689910.1016/j.jcrc.2017.06.019)
Wu MC, Liao TY, Lee EM, Chen YS, Hsu WT, Lee MG, Tsou PY, Chen SC, Lee CC (2017) Administration of hypertonic solutions for hemorrhagic shock: a systematic review and meta-analysis of clinical trials. Anesth Analg 125:1549–1557. (PMID: 2893093710.1213/ANE.0000000000002451)
Shrum B, Church B, McArthur E, Burns KE, Znajda T, McAlister V (2016) Hypertonic salt solution for peri-operative fluid management. Cochrane Database Syst Rev 2016:CD005576. (PMID: 272714808627702)

Keywords: Albumin; Colloid solutions; Critical care; Crystalloid solutions; Fluid therapy; Practice guidelines

0 (Crystalloid Solutions)
0 (Albumins)

Date Created: 20240521 Date Completed: 20240610 Latest Revision: 20240801

20240801

10.1007/s00134-024-07369-9

38771364